These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16310225)

  • 1. Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line.
    Radice S; Chiesara E; Frigerio S; Fumagalli R; Parolaro D; Rubino T; Marabini L
    Life Sci; 2006 May; 78(23):2716-23. PubMed ID: 16310225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic activity of procymidone in rainbow trout (Oncorhynchus mykiss) hepatocytes: a possible mechanism of action.
    Radice S; Fumagalli R; Chiesara E; Ferraris M; Frigerio S; Marabini L
    Chem Biol Interact; 2004 Mar; 147(2):185-93. PubMed ID: 15013820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic activity of procymidone in primary cultured rainbow trout hepatocytes (Oncorhynchus mykiss).
    Radice S; Ferraris M; Marabini L; Chiesara E
    Toxicol In Vitro; 2002 Aug; 16(4):475-80. PubMed ID: 12110288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and suppression of cytochrome P450 isoenzymes and generation of oxygen radicals by procymidone in liver, kidney and lung of CD1 mice.
    Sapone A; Affatato A; Canistro D; Broccoli M; Trespidi S; Pozzetti L; Biagi GL; Cantelli-Forti G; Paolini M
    Mutat Res; 2003 Jun; 527(1-2):67-80. PubMed ID: 12787915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro.
    Ostby J; Kelce WR; Lambright C; Wolf CJ; Mann P; Gray LE
    Toxicol Ind Health; 1999; 15(1-2):80-93. PubMed ID: 10188193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.
    Yue W; Wang JP; Conaway M; Masamura S; Li Y; Santen RJ
    Endocrinology; 2002 Sep; 143(9):3221-9. PubMed ID: 12193533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
    Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
    Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
    Lin CW; Yang LY; Shen SC; Chen YC
    J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of the breast cancer-promoter hormone, 5α-dihydroprogesterone (5αP), involves plasma membrane-associated receptors and MAPK activation.
    Wiebe JP; Pawlak KJ; Kwok A
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):166-76. PubMed ID: 26519986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for estrogenic contamination of the MAPK inhibitor PD98059.
    Long X; Gize EA; Nephew K; Bigsby RM
    Endocrinology; 2001 Dec; 142(12):5390-3. PubMed ID: 11713241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
    Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
    Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
    Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
    Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of PCB101, PCB118, PCB138 and PCB153 alone or mixed in MCF-7 breast cancer cells.
    Radice S; Chiesara E; Fucile S; Marabini L
    Food Chem Toxicol; 2008 Jul; 46(7):2561-7. PubMed ID: 18508174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.